ClinicalTrials.gov
ClinicalTrials.gov Menu

Pharmacokinetic, Safety/Tolerability Study of a Single SC Dose of PB1023 Injection in Subjects With Normal and Impaired Renal Function

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01478399
Recruitment Status : Completed
First Posted : November 23, 2011
Last Update Posted : April 15, 2013
Sponsor:
Information provided by (Responsible Party):
PhaseBio Pharmaceuticals Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : October 2012